ClinicalTrials.Veeva

Menu

Accuracy of Methemoglobin Measurement for Rainbow DCI Sensors

Masimo logo

Masimo

Status

Completed

Conditions

Healthy

Treatments

Device: DCI pulse oximeter sensor

Study type

Interventional

Funder types

Industry

Identifiers

NCT03124927
TR-17413-REDF0003

Details and patient eligibility

About

In this study, the level of methemoglobin (HbMet) will be increased in a controlled manner by administering sodium nitrite intravenously in healthy volunteers. The accuracy of a noninvasive HbMet measurement by a DCI pulse oximeter sensor will be assessed by comparison to blood measurements from a laboratory analyzer.

Enrollment

25 patients

Sex

All

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Subjects must understand and consent to be in the study
  2. American Society of Anesthesiology Class I (Healthy subjects without any systemic disease at all).

Exclusion criteria

  1. Subjects who have any systemic disease at all.
  2. Subjects who do not understand the study and the risks involved.
  3. Current smokers.
  4. Subjects who are pregnant.

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

25 participants in 1 patient group

Test Group
Experimental group
Description:
All subjects are enrolled into the test group and all subjects receive DCI pulse oximeter sensor.
Treatment:
Device: DCI pulse oximeter sensor

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems